Tim Hurley is a counsel in the firm’s Business Law department and a member of its Technology & Life Sciences group. He advises technology and life science companies through all stages of their life cycle, from formation and initial funding to exit. His practice includes company formation, venture capital financings, mergers and acquisitions, initial public offerings and general corporate and securities law. Tim also advises emerging companies through his work with New York Angels, which is one of the longest-running active angel groups in New York City. He joined Goodwin in 2012.
During law school, Tim represented two plaintiffs in litigation in the Eastern District of New York as part of New York University Law School’s Civil Rights Clinic with the NYCLU. In addition, he served as an article editor for the Annual Survey of American Law and was named a Robert McKay Scholar.
Experience
- Aircall.io, a cloud-based call center software company, in its $7.8 million Series A-3 financing led by Balderton Capital and its $29 million Series B financing led by Draper Esprit
- Akili Interactive Labs, a prescription digital medicine company, in its $55 million Series C financing led by Temasek
- Ambri, a liquid metal battery technology company, in its $144 million Series E financing led by Paulson, Reliance New Energy Solar Limited and Gates Frontier
- Arrive Health in numerous preferred stock financings led by University of Colorado Health, JAZZ Human Performance Fund and Providence Ventures
- Blispay, a financial technology company, as outside general counsel and in numerous preferred stock financings with Atlas Venture, NEA, FirstMark Capital and F-Prime Capital Partners
- CoBro Ventures in Frequency Therapeutics’ $32 million Series A financing
- F-Prime Capital Partners in Threat Stack’s $45 million Series C financing and in Hone’s Series A financing
- Galaxy Digital Ventures in the Series A-1 financing of Candy Digital
- Health Recovery Solutions, in preferred stock financings led by LLR Equity Partners and Edison Partners
- HiberCell, in numerous preferred stock financings led by ARCH Venture Partners, 6 Dimensions Capital, Hillhouse Capital and QIA
- Highland Capital Partners in Remote Year’s $12 million Series A financing
- Indi Molecular in its $11 million Series A financing led by Merck Ventures and Legend Capital Management
- Lighthouse.io, a cloud-based workforce management platform, as outside general counsel and its Series Seed financing led by Tamarisc Ventures and Morningside Technology Ventures
- Lucid, a market research technology company, in its $60 million Class B financing with North Bridge Venture Partners
- Lycera, a biopharmaceutical company developing immune modulatory medicines, in several bridge financings with ARCH Venture Partners, InterWest Partners, Clarus Ventures and EDF Ventures and in its Series B financing with Celgene
- New York Angels, in several early-stage investments
- PointClickCare, a leading provider of cloud-based software solutions for the senior care industry, in its $85 million Class B financing with Dragoneer Investment Group and JMI Equity
- Prove Identity (formerly Payfone), a leader in secure mobile authentication, in numerous preferred stock financings led by BlueCross BlueShield Venture Partners, Synchrony Financial, MassMutual Ventures, and Apax Partners
- Syntimmune, a clinical-stage biopharmaceutical company, as outside general counsel and in its $50 million Series B financing led by Apple Tree Partners
- Thrive Capital Partners in Rightway Healthcare’s $75 million Series D financing
- Ablynx in its $230 million U.S. initial public offering
- Celyad in its $100 million initial public offering
- Goldman Sachs and Morgan Stanley in the $300 million initial public offering of Blue Apron
- Mimecast in a $66 million follow-on secondary public offering
- Piper Jaffray and Stifel in the $59 million initial public offering of Innocoll
- AppNexus, a digital advertising technology company, in its sale to AT&T
- AppNexus in its acquisitions of YieldEx, a provider of publisher forecasting, pricing and direct-sales analytics, and MediaGlu, a cross-device technology business
- Chart.io, a provider of cloud-based data analytics, in its sale to Atlassian
- Heron Systems, an artificial intelligence company that builds practical, deployable autonomous agents and multi-agent systems powered by AI, in its sale to Shield AI
- Lighthouse.io in its sale to Team Software, a portfolio company of Accel-KKR
- MightyTV, a video discovery startup, in its sale to Spotify
- Par8o, a healthcare technology company specializing in 340B and patient referral management technology for healthcare providers, in its sale to Cloudmed Solutions, a portfolio company of New Mountain Capital
- Podium Data, an enterprise-grade data management company, in its sale to Qlik Technologies
- PointClickCare in its acquisitions of COMS Interactive, Med Management Technology, Collective Medical Technologies and Audacious Inquiry
- Sayspring, a provider of software allowing users to create interactive prototypes for voice applications, in its sale to Adobe
- Syntimmune in its sale to Alexion Pharmaceuticals
- TellusLabs, a leader in the use of satellite imaging for developing agricultural insights, in its sale to Indigo Agriculture
- Virtustream, a provider of cloud computing management software, in its sale to EMC
Credentials
Education
JD2012
New York University School of Law
(cum laude)
BA2004
Yale University
Admissions
Bars
- New York
Publications
Tim’s recent presentations include:
- Speaker, “High Growth Corporate Transactions: Stock Purchase and ROFR and Co-Sale Agreements,” Cornell Tech, February 2020
- Speaker, “High Growth Corporate Transactions: Investors’ Rights Agreement,” Cornell Tech, February 2019
- Speaker, “High Growth Corporate Transactions: Investors’ Rights Agreement,” Cornell Tech, February 2018
- Speaker, “Venture Capital 2017: Nuts and Bolts,” Practising Law Institute, June 2017